Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 2/20 | 0.30 |
| ▸ | MAOB | P27338 | 2/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL620862 | 0.82 | KDM4E (0.31) | — | |
| SCHEMBL6386579 | 0.80 | KDM1A (0.30) | KDM1A | |
| SCHEMBL6514980 | 0.75 | KDM1A (0.32) | KDM1AMAOAMAOB | |
| SCHEMBL6510367 | 0.73 | KDM1A (0.30) | KDM1AMAOAMAOB | |
| SCHEMBL3992251 | 0.69 | KDM1A (0.36) | TRPA1KDM1AMAOAMAOB | |
| SCHEMBL852864 | 0.68 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL1153469 | 0.68 | KDM1A (0.44) | KDM1AMAOAMAOB | |
| SCHEMBL13818654 | 0.66 | KDM1A (0.34) | KDM1AMAOAMAOB | |
| SCHEMBL11266183 | 0.66 | KDM1A (0.34) | KDM1AMAOAMAOB | |
| SCHEMBL20017698 | 0.66 | HTR2A (0.35) | KDM1AMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117881670-A | Methods of making EGFR inhibitors | 缆图药品公司 | 2024-04-12 | — | — | CN | claimed |
| US-7557248-B2 | Method of forming a carbon-heteroatom bond | RHODIA CHIMIE (FR) | 2009-07-07 | — | — | US | claimed |
| US-20070243999-A1 | Method of Forming a Carbon-Heteroatom Bond | RHODIA CHIMIE (FR) | 2007-10-18 | — | — | US | claimed |
| EP-1622861-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2006-02-08 | — | — | EP | claimed |
| WO-2005108338-A1 | NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLIC DISEASES AND SKIN DISORDERS | AUSPEX PHARMACEUTICALS (US) | 2005-11-17 | — | — | WO | claimed |
| WO-2004101496-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2004-11-25 | — | — | WO | claimed |
| CN-117881670-A | Methods of making EGFR inhibitors | 缆图药品公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117425653-A | Method for producing bipyridine derivative, method for producing macrocyclic compound, method for producing metal complex containing macrocyclic compound as ligand, metal complex, electrode for air battery, and air battery | 住友化学株式会社 | 2024-01-19 | — | — | CN | disclosed |
| US-20240018121-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| EP-4294814-A1 | METAL COMPLEXES HAVING 4-H, 6-H OR 8-H DIHYDROAZULENYL LIGANDS AND USE THEREOF | Umicore AG & Co. KG (DE) | 2023-12-27 | — | — | EP | disclosed |
| CN-117279909-A | Novel liver selective polyadenylation polymerase inhibitors and methods of use thereof | 巴鲁克斯布伦博格研究所 | 2023-12-22 | — | — | CN | disclosed |
| CN-117280489-A | Positive electrode mixture, positive electrode, and secondary battery | 大金工业株式会社 | 2023-12-22 | — | — | CN | disclosed |
| CN-117255779-A | Bisdiaminophenyl compound, crosslinking agent, composition and molded article | 大金工业株式会社 | 2023-12-19 | — | — | CN | disclosed |
| US-20110319393-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2011-12-29 | — | — | US | disclosed |
| WO-2011089985-A1 | COSMETIC COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2011-07-28 | — | — | WO | disclosed |
| WO-2010115688-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2010-10-14 | — | — | WO | disclosed |
| US-7557248-B2 | Method of forming a carbon-heteroatom bond | RHODIA CHIMIE (FR) | 2009-07-07 | — | — | US | disclosed |
| US-20070243999-A1 | Method of Forming a Carbon-Heteroatom Bond | RHODIA CHIMIE (FR) | 2007-10-18 | — | — | US | disclosed |
| EP-1622861-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004101496-A1 | METHOD OF FORMING A CARBON-HETEROATOM BOND | RHODIA CHIMIE (FR) | 2004-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319393-A1 | ANTHELMINTIC AGENTS AND THEIR USE | ACHE, ABCB11, MPO | TRPA1 293/4885KDM1A 1511/4885MAOA 1937/4885 |
| US-20240018121-A1 | NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE | ERG28, CYP51A1, MANBA | TRPA1 4481/4885KDM1A 2291/4885MAOA 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.